Taro Pharmaceutical Industries Ltd. (NYSE:TARO – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $40.01 and traded as high as $42.49. Taro Pharmaceutical Industries shares last traded at $42.40, with a volume of 27,051 shares. Analyst Upgrades and Downgrades A number […]
StockNews.com assumed coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO – Free Report) in a research report released on Sunday morning. The firm issued a strong-buy rating on the stock. Separately, HC Wainwright cut Taro Pharmaceutical Industries from a buy rating to a neutral rating and set a $43.00 target price on the stock. in […]
StockNews.com began coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO – Free Report) in a research note released on Thursday morning. The brokerage issued a strong-buy rating on the stock. Separately, HC Wainwright cut shares of Taro Pharmaceutical Industries from a buy rating to a neutral rating and set a $43.00 price objective on the […]
Taro Pharmaceutical Industries (NYSE:TARO – Get Free Report) is scheduled to issue its quarterly earnings data after the market closes on Thursday, January 25th. Analysts expect the company to announce earnings of $0.30 per share for the quarter. Taro Pharmaceutical Industries (NYSE:TARO – Get Free Report) last issued its earnings results on Thursday, October 26th. […]
StockNews.com upgraded shares of Taro Pharmaceutical Industries (NYSE:TARO – Free Report) from a buy rating to a strong-buy rating in a report issued on Tuesday. Separately, TheStreet raised Taro Pharmaceutical Industries from a d+ rating to a c- rating in a research note on Monday, June 26th. Check Out Our Latest Stock Analysis on TARO […]